Related Experiment Video
Updated: Jun 17, 2026
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
[Epidemiologic profile and prognostic factors in clinically localized prostate adenocarcinoma submitted to surgical
Aissar Eduardo Nassif1, Renato Tâmbara Filho, Regina Xavier Gomes de Paula
1Doutorando do Programa de Pós-Graduação em Clínica Cirúrgica da Universidade Federal do Paraná e Professor Adjunto da Universidade Ingá (UNINGA), Maringá, PR, Brasil. aenassif@gmail.com
Objective:
Radical prostatectomy remains the standard treatment for early prostate cancer. This study was conducted to evaluate the outcome and prognostic factors of radical prostatectomy.
Methods:
A total of 500 patients with prostate cancer underwent radical prostatectomy at Santa Rita hospital- Maringa-PR, between 2000 and 2006. Clinical staging, preoperative prostate-specific antigen (PSA) and Gleason score were evaluated with pathological stage and margin status. Follow-up PSA monitoring and survival were analyzed.
Results:
Of 500 patients with clinical localized disease with a median follow up of 36,7 + or - 18,8 months. The average operative duration was 190 + or - 45 minutes and the average intra-operative bleeding was 630 ml. The patients' preoperative serum PSA was 7,8 + or - 4,5 ng/dl , with a higher proportion of Gleason Score < 6(72%) and The TNM stage pT2c (65%). For late postoperative complications: incontinence in 2% and 46 % with erectile dysfunction.
Conclusion:
Radical prostatectomy in men shows excellent results. The chance of recurrence was directly associated with PSA = 10 ng/ml, high Gleason score and inversely proportional to age.
